dipyridamole has been researched along with Carbon Tetrachloride Poisoning in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Carbon Tetrachloride Poisoning: Poisoning that results from ingestion, injection, inhalation, or skin absorption of CARBON TETRACHLORIDE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jabłońska-Kaszewska, I | 1 |
| Dabrowska, E | 1 |
| Boj, E | 1 |
| Baranowska, B | 1 |
| Vogel, M | 1 |
1 other study available for dipyridamole and Carbon Tetrachloride Poisoning
| Article | Year |
|---|---|
[Effect of dipyridamole on liver changes during acute poisoning with carbon tetrachloride in rats].
Topics: Acute Disease; Animals; Antidotes; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver I | 1979 |